Annals of the New York Academy of Sciences · 2002 · 29 citations · 5 references
MedicineEndocrinologyImmunologyAutoimmunityDiabetologyImmunopathologyAutoantibodiesAutoimmune Disease PathogenesisAutoimmune DiseasesAutoimmune EndocrinopathiesCeliac DiseaseDiabetes MellitusAnti-glutamic Acid Decarboxylase AntibodiesAnti-transglutaminase AntibodiesAntibodiesAutoimmune SerologyCeliac Disease SerologyCeliac SerologyGlutamic Acid Decarboxylase AntibodiesIslet Autoimmunity
This study attempts to assess the prevalence of various autoantibodies in early-onset diabetics in northern India, with emphasis on antibodies against glutamic acid decarboxylase (GAD65), IA-2, ICA-12, 21-hydroxylase (21-OH), and tissue transglutaminase (TTG). GAD65 and IA-2 antibodies were found to be present in approximately 26% of cases of type 1 diabetes. A subset of patients clinically diagnosed to have MMDM appears to have an autoimmune etiology, with more than 20% showing serpositivity for IA-2 antibodies. Antibodies against ICA-12 were prevalent in both type 1 diabetes and MMDM. Approximately one of seven patients with type 1 diabetes showed erological evidence of celiac disease.
5
Cloning and Expression of IDDM-Specific Human Autoantigens
Daniel U. Rabin, Susan M Pleasic, Rebecca Palmer-Crocker et al. · Diabetes · 1992 · 119 citations
Autoantibodies to ICA12 (SOX-13) are not specific for Type I diabetes
Holger Steinbrenner, Tobias Lohmann, B. Ostendorf et al. · Diabetologia · 2000 · 13 citations · Full text